Status:
COMPLETED
Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence
Lead Sponsor:
Barrie Urology Associates
Collaborating Sponsors:
Astellas Pharma Canada, Inc.
Conditions:
Urinary Bladder, Overactive
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Pubovaginal sling (PVS) procedures are designed to curtail bladder leakage brought about by strenuous events such as child birth. A common purported side effect of PVS is urgency, the feeling of a com...
Eligibility Criteria
Inclusion
- Inclusion Criteria.
- Post-pubovaginal sling patient.
- Complete agreement and signing of Informed Consent Form.
- Exclusion Criteria.
- Currently taking antimuscarinics or α1 blockers.
- Patients with urinary retention, dependent on dialysis, gastroparesis or narrow angle glaucoma.
Exclusion
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01194999
Start Date
October 1 2010
End Date
June 1 2012
Last Update
September 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barrie Urology Associates - The Male/Female Health and Research Centre
Barrie, Ontario, Canada, L4M 7G1